CCND2 POSITIVE

Clinical trials for CCND2 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new CCND2 POSITIVE trials appear

Sign up with your email to follow new studies for CCND2 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Promising combo tackles tough lymphoma in older and relapsed patients

Disease control Ongoing

This study tests a combination of two drugs, ibrutinib and rituximab, in people with mantle cell lymphoma that has returned or not responded to treatment, as well as in older patients newly diagnosed with the disease. The goal is to see how well the drugs work together to shrink …

Matched conditions: CCND2 POSITIVE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 15, 2026 19:03 UTC

CCND2 POSITIVE

Get alerted when new CCND2 POSITIVE trials appear

Promising combo tackles tough lymphoma in older and relapsed patients